Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
INSTEM Aktie jetzt für 0€ handeln | |||||
Do | Instem Strengthens Commitment to End-to-End Preclinical Platform Amid Regulatory Evolution | 179 | Business Wire | Following the FDA's recent announcement expanding flexibility in preclinical submission evidence, Instem is reaffirming its role as the industry's trusted provider of an end-to-end preclinical platform... ► Artikel lesen | |
08.01. | Instem Introduces Cloud-Hosted Non-GLP Pathology Module for Provantis | 157 | Business Wire | Streamlining Pathology Workflows with Modern, Integrated Tools
Instem, a global leader in IT solutions for life sciences, has announced the launch of its new Non-GLP Pathology Module for Provantis... ► Artikel lesen | |
13.06.24 | Pathcore Inc.: Pathcore Announces Strategic Partnership With Instem to Enhance Digital Pathology Solutions for Toxicologic Pathology Workflows | 791 | ACCESS Newswire | TORONTO, ON / ACCESSWIRE / June 13, 2024 / Pathcore Inc., a leader in digital pathology software solutions, is pleased to announce a strategic partnership with Instem, a leading provider of IT solutions... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
---|